Adam Ron
Stock Analyst at B of A Securities
(2.41)
# 2,235
Out of 4,829 analysts
15
Total ratings
54.55%
Success rate
10.34%
Average return
Main Sectors:
Stocks Rated by Adam Ron
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALHC Alignment Healthcare | Maintains: Buy | $16 → $19 | $14.92 | +23.99% | 1 | Mar 4, 2025 | |
| ASTH Astrana Health | Maintains: Buy | $55 → $49 | $28.54 | +71.69% | 1 | Mar 4, 2025 | |
| OSCR Oscar Health | Downgrades: Underperform | $21 → $14 | $16.82 | -19.74% | 11 | Nov 6, 2024 | |
| PRVA Privia Health Group | Downgrades: Neutral | $27 → $21 | $25.06 | -16.20% | 2 | Feb 22, 2024 |
Alignment Healthcare
Mar 4, 2025
Maintains: Buy
Price Target: $16 → $19
Current: $14.92
Upside: +23.99%
Astrana Health
Mar 4, 2025
Maintains: Buy
Price Target: $55 → $49
Current: $28.54
Upside: +71.69%
Oscar Health
Nov 6, 2024
Downgrades: Underperform
Price Target: $21 → $14
Current: $16.82
Upside: -19.74%
Privia Health Group
Feb 22, 2024
Downgrades: Neutral
Price Target: $27 → $21
Current: $25.06
Upside: -16.20%